Cargando…

Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation

Detalles Bibliográficos
Autores principales: Shohat, Noam, Goswami, Karan, Breckenridge, Leigham, Held, Michael B., Malkani, Arthur L., Shah, Roshan P., Schwarzkopf, Ran, Parvizi, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329162/
https://www.ncbi.nlm.nih.gov/pubmed/34341393
http://dx.doi.org/10.1038/s41598-021-94867-1
_version_ 1783732439081811968
author Shohat, Noam
Goswami, Karan
Breckenridge, Leigham
Held, Michael B.
Malkani, Arthur L.
Shah, Roshan P.
Schwarzkopf, Ran
Parvizi, Javad
author_facet Shohat, Noam
Goswami, Karan
Breckenridge, Leigham
Held, Michael B.
Malkani, Arthur L.
Shah, Roshan P.
Schwarzkopf, Ran
Parvizi, Javad
author_sort Shohat, Noam
collection PubMed
description
format Online
Article
Text
id pubmed-8329162
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83291622021-08-04 Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation Shohat, Noam Goswami, Karan Breckenridge, Leigham Held, Michael B. Malkani, Arthur L. Shah, Roshan P. Schwarzkopf, Ran Parvizi, Javad Sci Rep Author Correction Nature Publishing Group UK 2021-08-02 /pmc/articles/PMC8329162/ /pubmed/34341393 http://dx.doi.org/10.1038/s41598-021-94867-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Shohat, Noam
Goswami, Karan
Breckenridge, Leigham
Held, Michael B.
Malkani, Arthur L.
Shah, Roshan P.
Schwarzkopf, Ran
Parvizi, Javad
Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title_full Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title_fullStr Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title_full_unstemmed Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title_short Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
title_sort author correction: fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329162/
https://www.ncbi.nlm.nih.gov/pubmed/34341393
http://dx.doi.org/10.1038/s41598-021-94867-1
work_keys_str_mv AT shohatnoam authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT goswamikaran authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT breckenridgeleigham authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT heldmichaelb authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT malkaniarthurl authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT shahroshanp authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT schwarzkopfran authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation
AT parvizijavad authorcorrectionfructosamineisavaluablemarkerforglycemiccontrolandpredictingadverseoutcomesfollowingtotalhiparthroplastyaprospectivemultiinstitutionalinvestigation